Home » Topics » Disease categories and therapies » Immune

Immune
RSS

S-28828: 3M's imiquimod analogue

June 7, 1996

Dimethaid Research announces encouraging results with its immunomodulator

May 31, 1996

Meningococcal protein with vaccine potential

May 31, 1996

Ruthenium complexes revealed by Procept

May 31, 1996

Merck's pediatric pneumococcal conjugate vaccine in advanced trials

May 24, 1996

HPV vaccine in phase I at Merck & Co.

May 24, 1996

New finding may help in overcoming bacterial resistance

May 17, 1996

SKB and MicroCarb to collaborate on bacterial vaccines

May 17, 1996

Vical, Pasteur Merieux Connaught expand naked DNA vaccine collaboration

May 17, 1996

IMP dehydrogenase inhibitor synthesized at Roche Bioscience

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...